Status:
COMPLETED
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
Lead Sponsor:
Eric Turcotte
Conditions:
Lymphoma, Large-Cell
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Patients affected with non-Hodgkin's large B-cell lymphoma are treated by chemotherapy. The evaluation of the response to this treatment is made by Positron Emission Tomography (PET/CT) in many centre...
Detailed Description
Participation in this study involves 4 PET/CT exams, which occur before the treatments start, after the first cycle of chemotherapy, after 4 cycles of chemotherapy and then 12 weeks after the end of t...
Eligibility Criteria
Inclusion
- Newly diagnosed large B cells non Hodgkin's lymphoma, CD20 positive
- Chemotherapy treatments planned (R-CHOP) but not started
Exclusion
- Pregnancy (determined by urinary β-HCG and blood test)
- Patients younger than 18 years
- Unable to tolerate the procedure (30 minutes laying down on the back)
- No chemotherapy treatment planned secondary to the patient's health performance
- Previous lymphoma that has been treated with chemotherapy with the exception of stade I lymphoma treated only with radiotherapy.
- All lymphoma other than large cell Non Hodgkin's lymphoma
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00256490
Start Date
November 1 2005
End Date
December 1 2009
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec, Canada, J1H 5N4